Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) has been given an average rating of “Moderate Buy” by the twelve ratings firms ...

On Tuesday, Cathie Wood -led Ark Invest made significant trades involving Tempus AI Inc. TEM , Advanced Micro Devices Inc.

In the biotech sphere, ARK ETFs continued to accumulate shares of CRISPR Therapeutics AG (NASDAQ: CRSP) and Intellia Therapeutics Inc (NASDAQ: NTLA ), with purchases of 67,787 and 194,844 shares, ...

During a Community Case Forum event in partnership with the Texas Society of Clinical Oncology, Natalie Vokes, MD, discussed trials of targeted agents for EGFR-mutant lung cancer.

Kimia Therapeutics, Inc. (Kimia), a biotechnology company generating a chemical atlas for treating human disease, today announced the appointment of Imran S. Haque, Ph.D., to the role of chief ...

Tempus AI's financials have significantly improved, with positive cash flow expected next quarter. Read why TEM stock is a ...

Ilyce Glink, owner of Think Glink Media and Best Money Moves, joins WGN’s John Williams to give updates on the markets along ...

A new precision oncology paper was published in Oncotarget, Volume 16, on March 12, 2025, titled “Worldwide Innovative ...

Guardant Health Inc.'s genomic data-powered technologies for accelerating drug development infringe Tempus AI Inc.'s “groundbreaking” cancer research patents, according to a federal lawsuit.

We recently published a list of 11 AI News Updates Investors Should Not Miss. In this article, we are going to take a look at ...

The Bureau of Labor Statistics reported Wednesday that February prices for food and services haven’t gone up as much as many ...

Super Micro Computer, ServiceNow, Salesforce, Accenture, Tempus AI, Arista Networks, and SoundHound AI are the seven ...